Sequence variants in toll-like receptor 10 are associated with nasopharyngeal carcinoma risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 5, 2006, Pages 862-866

  Zhou, Xin Xi ^a   Jia, Wei Hua ^a   Shen, Guo Ping ^a   Qin, Hai De ^a   Yu, Xing Juan ^a   Chen, Li Zhen ^a   Feng, Qi Sheng ^a   Shugart, Yin Yao ^b   Zeng, Yi Xin ^a,c  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 10;

ADULT; ANTIBODY TITER; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALGORITHMS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 10; VARIATION (GENETICS);

EID: 33744720397     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0874     Document Type: Article

References (38)

1. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 2002;12:421-9.
2. McDermott AL, Dutt SN, Watkinson JC. The aetiology of nasopharyngeal carcinoma. Clin Otolaryngol 2001;26:82-92.
3. Jia WH, Collins A, Zeng YX, et al. Complex segregation analysis of nasopharyngeal carcinoma in Guangdong, China: evidence for a multifactorial mode of inheritance (complex segregation analysis of NPC in China). Eur J Hum Genet 2005;13:248-52.
4. Zeng YX, Jia WH. Familial nasopharyngeal carcinoma. Semin Cancer Biol 2002;12:443-50.
5. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4:757-68.
6. Yang XR, Diehl S, Pfeiffer R, et al. Chinese and American Genetic Epidemiology of NPC Study Team. Evaluation of risk factors for nasopharyngeal carcinoma in high-risk nasopharyngeal carcinoma families in Taiwan. Cancer Epidemiol Biomarkers Prev 2005;14:900-5.
7. Ng WT, Yau TK, Yung RW, et al. Screening for family members of patients with nasopharyngeal carcinoma. Int J Cancer 2005;113:998-1001.
8. Rickinson AB, Kieff E. Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology. 3rd ed. vol. 2. Philadelphia: Lippincott-Raven Publishers; 1996. p. 2397-446.
9. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC [review]. Semin Cancer Biol 2002;12:431-41.
10. Yu MC, Henderson BE. Intake of Cantonese-style salted fish as a cause of nasopharyngeal carcinoma. IARC Sci Publ 1987;84:547-9.
11. IARC. Some naturally occurring substances. Food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC Monograph. Vol. 56. Lyon: IARC Press; 1993.
12. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004;83:1-1438.
13. Lu CC, Chen JC, Jin YT, Yang HB, Chan SH, Tsai ST. Genetic susceptibility to nasopharyngeal carcinoma within the HLA-A locus in Taiwanese. Int J Cancer 2003;103:745-51.
14. Ooi EE, Ren EC, Chan SH. Association between microsatellites within the human MHC and nasopharyngeal carcinoma. Int J Cancer 1997;74:229-32.
15. Hildesheim A, Apple RJ, Chen CJ, et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 2002;94:1780-9.
16. Goldsmith DB, West TM, Morton R. HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis. Clin Otolaryngol 2002;27:61-7.
17. Nazar-Stewart V, Vaughan TL, Burt RD, Chen C, Berwick M, Swanson GM. Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 1999;8:547-51.
18. Hildesheim A, Anderson LM, Chen CJ, et al. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 1997;89:1207-12.
19. Cho EY, Hildesheim A, Chen CJ, et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev 2003;12:1100-4.
20. Brancolini V, Devoto M. Genetic linkage studies for the identification of cancer-related genes. Ann Ist Super Sanita 1996;32:173-80.
21. Feng BJ, Huang W, Shugart YY, et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet 2002;31:395-9.
22. Chen HK, Zhang RH, Feng BJ, Liang H, Zeng YX. The susceptibility gene for familial nasopharyngeal carcinoma is mapped on chromosome 4p11-14 by haplotype analyses. Chin Sci Bull 2003;48:2327-30.
23. Nau GJ, Schlesinger A, Richmond JF, Young RA. Cumulative Toll-like receptor activation in human macrophages treated with whole bacteria. J Immunol 2003;170:5203-9.
24. Roeder A, Kirschning CJ, Rupec RA, Schaller M, Weindl G, Korting HC. Toll-like receptors as key mediators in innate antifungal immunity [review]. Med Mycol 2004;42:485-98.
25. Heil F, Hemmi H, Hochrein H, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004;303:1526-9.
26. Huang B, Zhao J, Li H, et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 2005;65:5009-14.
27. Chuang T, Ulevitch RJ. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 2001;1518:157-61.
28. Zheng SL, Augustsson-Balter K, Chang B, et al. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the Cancer Prostate in Sweden Study. Cancer Res 2004;64:2918-22.
29. Sun J, Wiklund F, Zheng SL, et al. Sequence variants in Toll-like receptor gene cluster (TLR6-1-TLR10) and prostate cancer risk. J Natl Cancer Inst 2005;97:525-32.
30. Zhang K, Qin Z, Chen T, Liu JS, Waterman MS, Sun F. HapBlock: haplotype block partitioning and tag SNP selection software using a set of dynamic programming algorithms. Bioinformatics 2005;21:131-4.
31. Mutirangura A. Molecular mechanisms of nasopharyngeal carcinoma development. Res Adv Res Updat Med 2000;1:18-27.
32. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas D. Cancer incidence in five continents. Vol. VIII. IARC scientific publication no. 155. Lyon: IARC Press; 2003.
33. Cheung F, Pang SW, Hioe F, Cheung KN, Lee A, Yau TK. Nasopharyngeal carcinoma in situ : two cases of an emerging diagnostic entity. Cancer 1998;83:1069-73.
34. Mutirangura A, Tanunyutthawongese C, Pornthanakasem W, et al. Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection. Br J Cancer 1997;76:770-6.
35. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995;333:693-8.
36. Kuppers R. B cells under influence: transformation of B cells by Epstein-Barr virus [review]. Nat Rev Immunol 2003;3:801-12.
37. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses [review]. Nat Immunol 2004;5:987-95.
38. Rifkin IR, Leadbetter EA, Busconi L, Viglianti G, Marshak-Rothstein A. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 2005;204:27-42.